Daiichi Life Group. Inc. TSE:8750

Daiichi Life : Consolidated Financial ResultsPDF file will open in a new window (2025 001)

Published

Source: MarketScreener

(Unofficial Translation)

Consolidated Summary Report under Japanese GAAP for the Fiscal Year Ended March 31, 2026

Company Name: Daiichi Life Group, Inc. Stock exchange listings: Tokyo

May 15, 2026

Code Number: 8750 URL: https://www.daiichilife-group.com/ Representative: Tetsuya Kikuta, President, Representative Director

For inquiry: Shunsuke Murakami, General Manager, Investor Relations Group, Corporate Planning Unit TEL: (03)3216-1222

General meeting of shareholders: June 22, 2026 Dividend payment date: June 23, 2026 Securities report issue date: June 16, 2026

Supplementary information for financial statements: Available

Explanatory meeting to be held: Yes (for institutional investors and analysts)

(Amounts of less than one million yen are truncated.)

  1. Consolidated Financial Data for the Fiscal Year Ended March 31, 2026
    1. Consolidated results of operations

      (% represents the change from the previous fiscal year)

      Ordinary Revenues

      Ordinary Profit

      Net Income attributable to shareholders of Parent Company

      Fiscal Year Ended

      Unit: million yen

      %

      Unit: million yen

      %

      Unit: million yen

      %

      March 31, 2026

      11,308,275

      14.5

      753,688

      (0.3)

      436,597

      (4.8)

      March 31, 2025

      9,876,615

      (10.4)

      755,728

      40.2

      458,407

      42.9

      Note. Comprehensive income (loss) for the fiscal years ended March 31, 2026 and 2025 were 817,590 million yen and (75,635) million yen, respectively.

      Net Income per Share

      Diluted Net Income per Share

      Ratio of Net Income to Shareholders' Equity

      Ratio of Ordinary Profits to Total Assets

      Ratio of Ordinary Profits to Ordinary Revenues

      Fiscal Year Ended

      yen

      yen

      %

      %

      %

      March 31, 2026

      119.83

      119.82

      11.1

      1.0

      6.7

      March 31, 2025

      123.72

      123.70

      12.2

      1.1

      7.7

      (Reference) Income (loss) from investment in affiliates (Equity method) March 31, 2026: 23,055 million yen March 31, 2025: 3,526 million yen Note. The Company conducted a 1:4 share split on April 1, 2025. Net income per share and diluted net income per share are calculated,

      assuming that the share split was conducted at the beginning of the previous fiscal year.

    2. Consolidated financial condition

      Total Assets

      Total Net Assets

      Ratio of Net Assets Attributable to the Company's shareholders

      to Total Assets

      Total Net Assets per Share

      As of

      Unit: million yen

      Unit: million yen

      %

      yen

      March 31, 2026

      74,159,096

      4,254,212

      5.7

      1,181.36

      March 31, 2025

      69,404,123

      3,639,369

      5.2

      988.61

      (Reference) Net assets attributable to the Company's shareholders as of March 31, 2026 and 2025 were 4,254,002 million yen and 3,639,112 million yen,respectively.

      Note. The Company conducted a 1:4 share split on April 1, 2025. Total net assets per share are calculated, assuming that the share split was conducted at the beginning of the previous fiscal year.

    3. Consolidated cash flows

    Cash flows from operating activities

    Cash flows from investing activities

    Cash flows from financing activities

    Cash and cash equivalents at the end of the year

    Fiscal Year Ended

    Unit: million yen

    Unit: million yen

    Unit: million yen

    Unit: million yen

    March 31, 2026

    792,158

    (926,255)

    (127,230)

    2,087,588

    March 31, 2025

    592,578

    (980,460)

    (73,570)

    2,313,529

  2. Dividends on Common Stock

    Dividends per share

    Total Dividends (Annual)

    Dividend payout ratio (Consolidated)

    Dividend on net assets ratio (Consolidated)

    1st quarter-end

    2nd quarter-end

    3rd quarter-end

    Fiscal year-end

    Annual

    Fiscal Year Ended

    yen

    yen

    yen

    yen

    yen

    million yen

    %

    %

    March 31, 2025

    -

    61.00

    -

    76.00

    137.00

    126,075

    29.5

    3.5

    March 31, 2026

    -

    24.00

    -

    30.50

    54.50

    197,225

    45.5

    5.0

    March 31, 2027

    (Forecast)

    -

    36.00

    -

    36.00

    72.00

    50.5

    Note 1. "Total dividends (Annual)" in the above table excludes dividends of 578 million yen for the fiscal year ended March 31, 2025 and dividends of 866 million yen for the fiscal year ended March 31, 2026 to shares held by the Stock Granting Trust (J-ESOP trust).

    2. The Company conducted a 1:4 share split on April 1, 2025. The dividend per share for the fiscal year ended March 31, 2025 does not reflect the share split. Contents for the fiscal year ended March 31, 2026 and fiscal year ending March 31, 2027 (forecast) are stated in figures after the share split.

  3. Consolidated Earnings Forecasts for the Fiscal Year ending March 31, 2027

    (% represents the change from the previous fiscal year)

    Ordinary Revenues

    Ordinary Profit

    Net Income attributable to shareholders of Parent Company

    Net Income per Share

    Fiscal Year Ending

    Unit: million yen

    %

    Unit: million yen

    %

    Unit: million yen

    %

    yen

    March 31, 2027

    10,666,000

    (5.7)

    869,000

    15.3

    513,000

    17.5

    142.46

    Note. The Company conducted a 1:4 share split on April 1, 2025. Net income per share in Forecasts of Consolidated Financial Results for the fiscal year ending March 31, 2027 has taken the impact of the said share split into account.

  4. Notes
  1. Significant changes in the scope of consolidation during the period :No

  2. Changes in accounting policies, accounting estimates and correction of past errors:Yes

    1. Changes in accounting policies due to revision of accounting standards:Yes

    2. Changes in accounting policies due to reasons other than item (A) above:No

    3. Changes in accounting estimates:No

    4. Correction of past errors:No

      (3) Number of shares outstanding (common stock)

      As of March 31, 2026

      As of March 31, 2025

      (A) Total shares outstanding including treasury stock:

      3,621,895,219

      3,700,398,400

      (B) Shares of treasury stock held:

      20,944,204

      19,361,896

      Year ended March 31, 2026

      Year ended March 31, 2025

      (C) Average outstanding shares:

      3,643,385,226

      3,705,314,875

      Note.

      1. For the number of shares used as the basis for the calculation of consolidated net income per share, please refer to (Per-share information),

        (5) Notes to the Consolidated Financial Statements, under [3. Unaudited Consolidated Financial Statements] of the Appendix.

      2. The Company conducted a 1:4 share split on April 1, 2025. The number of shares is calculated assuming that the share split was conducted at the beginning of the previous fiscal year.

      3. The number of treasury stocks includes the shares of the Company (18,079,918 shares as of March 31, 2026 and 16,903,200 shares as of March 31, 2025) held by the Stock Granting Trust (J-ESOP trust).

(Reference) Non-consolidated Financial Data
  1. Non-consolidated Financial Data for the Fiscal Year Ended March 31, 2026
    1. Non-consolidated results of operations

      (% represents the change from the previous fiscal year)

      Sales Revenues

      Operating Profit

      Fiscal Year Ended

      Unit: million yen

      %

      Unit: million yen

      %

      March 31, 2026

      334,518

      48.3

      300,264

      51.0

      March 31, 2025

      225,620

      15.4

      198,865

      11.8

      Ordinary Profit

      Net Income

      Fiscal Year Ended

      Unit: million yen

      %

      Unit: million yen

      %

      March 31, 2026

      288,783

      51.8

      295,300

      63.5

      March 31, 2025

      190,248

      10.8

      180,629

      3.6

      Net Income per Share

      Diluted Net Income per Share

      Fiscal Year Ended

      yen

      yen

      March 31, 2026

      81.05

      81.04

      March 31, 2025

      48.75

      48.74

      Note. The Company conducted a 1:4 share split on April 1, 2025. Net income per share and diluted net income per share are calculated, assuming that the share split was conducted at the beginning of the previous fiscal year.

    2. Non-consolidated financial condition

    Total Assets

    Total Net Assets

    Ratio of Net Assets Attributable to the Company's shareholders

    to Total Assets

    Total Net Assets per Share

    As of

    Unit: million yen

    Unit: million yen

    %

    yen

    March 31, 2026

    2,771,624

    1,238,860

    44.7

    343.98

    March 31, 2025

    2,508,002

    1,197,842

    47.8

    325.34

    (Reference) Net assets attributable to the Company's shareholders as of March 31, 2026 and 2025 were 1,238,650 million yen and 1,197,584 million yen, respectively.

    Note. The Company conducted a 1:4 share split on April 1, 2025. Total net assets per share are calculated, assuming that the share split was conducted at the beginning of the previous fiscal year.

    *This report is exempt from the audits of CPAs or Audit firms.

    *Notes for using earnings forecast in this report and others:

    This report contains forward-looking statements, such as earnings forecasts, regarding the intent, beliefs and current expectations of the Company and its management with respect to the expected financial condition and results of operations of the Company. These statements necessarily depend upon information currently available to the Company and its management and on assumptions that the Company and its management believe are appropriate. Forward-looking statements are not guarantees of future performance and actual results may differ materially from any future results expressed or implied by forward-looking statements. Forward-looking statements are subject to various risks and uncertainties, such as fluctuations in market conditions, including changes in the value of equity securities and changes in interest rates and forward exchange rates, the occurrence of illegal acts, operational and system risks, risks associated with general economic conditions in Japan and other factors. Important factors which may affect the Company's financial condition, results of operations and business performance are not limited to the factors described above. In light of the risks and uncertainties relating to forward-looking statements, investors are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this release.

    The Company has changed its trade name from Dai-ichi Life Holdings, Inc. to its current name (Daiichi Life Group, Inc.) on the effective date of April 1, 2026.

    Table of Contents of Appendix
    1. Consolidated Results of Operations 2

      1. Results of Operations and Financial Condition 2

      2. Forecasts 3

    2. Basic Rationale for Selection of Accounting Standards 4

    3. Unaudited Consolidated Financial Statements 5

    1. Consolidated Balance Sheet 5

    2. Consolidated Statement of Earnings and Comprehensive Income 7

      Consolidated Statement of Earnings 7

      Consolidated Statement of Comprehensive Income 9

    3. Consolidated Statement of Changes in Net Assets 10

    4. Consolidated Statement of Cash Flows 14

    5. Notes to the Consolidated Financial Statements 16

    (Notes on Going-Concern Assumptions) 16

    (Segment Information and Others) 17

    (Per-share Information) 20

    (Subsequent Events) 20

    The Company plans to hold a conference call for institutional investors and analysts regarding its financial results for the fiscal year ended March 31, 2026 on May 15, 2026. The material for the conference call will be posted on TDnet and the Company's website.

    1. Consolidated Results of Operations

      1. Results of Operations and Financial Condition

        1. Results of Operations for the Fiscal Year Ended March 31, 2026

          • Ordinary revenues of Dai-ichi Life Holdings, Inc. (hereinafter the "Company" or the "Parent Company") and its consolidated subsidiaries (collectively, the "Group") for the fiscal year ended March 31, 2026 increased by 1,431.6 billion yen, or 14.5%, to 11,308.2 billion yen, consisting of (1) 6,944.0 billion yen (2.1% increase) of premium and other income, (2) 3,735.3 billion yen (47.7% increase) of investment income, and (3) 628.8 billion yen (14.6% increase) of other ordinary revenues, compared to the prior fiscal year. Premium and other income increased due mainly to the increase in sales at The Dai-ichi Frontier Life Insurance Co., Ltd.

          • Meanwhile, the Group's ordinary expenses for the fiscal year ended March 31, 2026 increased by 15.7%, to 10,554.5 billion yen, consisting of (1) 6,447.1 billion yen (2.0% decrease) of benefits and claims, (2) 1,814.9 billion yen (430.8% increase) of provision for policy reserves and others, (3) 867.0 billion yen (3.0% increase) of investment expenses, (4) 1,048.2 billion yen (6.1% increase) of operating expenses, and (5) 377.2 billion yen (2.7% increase) of other ordinary expenses, compared to the prior fiscal year.

          • Consequently, the Group's ordinary profit for the fiscal year ended March 31, 2026, compared to the prior fiscal year, decreased by 2.0 billion yen or 0.3%, to 753.6 billion yen. Its net income attributable to shareholders of parent company for the fiscal year, which is ordinary profit after extraordinary gains and losses, provision for reserve for policyholder dividends, and total of corporate income taxes, decreased by 4.8%, to 436.5 billion yen.

          • Net income attributable to shareholders of parent company for the fiscal year decreased compared to the prior fiscal year. The decrease was due mainly to the application of the new U.S. insurance accounting standard by Protective Life Corporation.

          • Dai-ichi Life Holdings, Inc. changed its trade name to Daiichi Life Group, Inc. on April 1, 2026.

          • The Dai-ichi Frontier Life Insurance Co., Ltd. changed its trade name to Daiichi Frontier Life Insurance Co., Ltd. on April 1, 2026.

        2. Financial Condition as of March 31, 2026

          1. Condition of assets, liabilities, and net assets

            • The Group's total assets as of March 31, 2026, compared to March 31, 2025, increased by 6.9%, to 74,159.0 billion yen, mainly consisting of 55,576.2 billion yen (4.8% increase) of securities, 4,997.1 billion yen (2.6% decrease) of loans, 1,239.2 billion yen (2.7% decrease) of tangible fixed assets, and 2,062.9 billion yen (0.7% increase) of reinsurance receivable.

            • The Group's total liabilities as of March 31, 2026 increased by 6.3% to 69,904.8 billion yen, mainly consisting of 61,255.1 billion yen (3.4% increase) of policy reserves and others, compared to March 31, 2025.

            • The Group's total net assets as of March 31, 2026 increased by 16.9% to 4,254.2 billion yen. Net unrealized gains on securities, net of tax, as of March 31, 2026, which are included in the Group's total net assets, increased by 43.1% to 1,372.6 billion yen.

          2. Cash flows

            • Cash Flows from Operating Activities

              The Company's net cash flows provided in operating activities for the fiscal year ended March 31, 2026 increased by 199.5 billion yen to 792.1 billion yen, compared to the prior fiscal year.

            • Cash Flows from Investing Activities

              The Company's net cash flows used by investing activities for the fiscal year ended March 31, 2026 decreased by

              54.2 billion yen to 926.2 billion yen, compared to the prior fiscal year.

            • Cash Flows from Financing Activities

              The Company's net cash flows used by financing activities for the fiscal year ended March 31, 2026 increased by

              53.6 billion yen to 127.2 billion yen, compared to the prior fiscal year.

            • Cash and Cash Equivalents at the End of the Year

            As a result, the Company's cash and cash equivalents as of March 31, 2026 decreased by 225.9 billion yen to 2,087.5 billion yen from 2,313.5 billion yen at the end of the prior fiscal year.

      2. Forecasts

      • The Company forecasts its consolidated ordinary revenues to decrease compared to the previous fiscal year to 10,666.0 billion yen, mainly due to the decrease in investment income at Protective Life Corporation. The Company also forecasts ordinary profit and net income attributable to shareholders of parent company to increase to 869.0 billion yen and 513.0 billion yen, respectively, mainly due to the increase in the overseas life insurance businesses.

      • The above forecasts are based on the Company's current expectations, taking into account factors such as the information currently available and past experience, and assuming that interest rates, forward exchange rates and stock prices do not substantially vary from those as of March 31, 2026. Therefore, actual results may substantially differ from the forecasts.

    2. Basic Rationale for Selection of Accounting Standards

      The Group is evaluating International Financial Reporting Standards (IFRS), assuming that the Group will adopt IFRS in the future.

      Regarding the accounting standards for insurance contracts (IFRS 17), taking into account the potential effect on the method of creating financial statements, we are continuously examining their progress.

    3. Unaudited Consolidated Financial Statements

    (1) Consolidated Balance Sheet

    ASSETS

    As of

    March 31, 2025

    (Unit: million yen) As of

    March 31, 2026

    Cash and deposits

    1,889,228

    1,974,671

    Call loans

    566,500

    591,000

    Monetary claims bought

    207,197

    186,044

    Money held in trust

    899,485

    1,384,128

    Securities

    53,033,910

    55,576,274

    Loans

    5,130,891

    4,997,117

    Tangible fixed assets

    1,273,200

    1,239,280

    Land

    881,367

    836,165

    Buildings

    342,470

    362,617

    Leased assets

    8,432

    6,919

    Construction in progress

    8,496

    1,011

    Other tangible fixed assets

    32,432

    32,566

    Intangible fixed assets

    1,044,116

    963,435

    Software

    143,253

    139,206

    Goodwill

    328,427

    302,276

    Leased assets

    3

    1

    Other intangible fixed assets

    572,431

    521,950

    Reinsurance receivable

    2,048,027

    2,062,981

    Other assets

    3,195,461

    5,075,928

    Deferred tax assets

    125,713

    125,244

    Customers' liabilities for acceptances and guarantees

    11,192

    4

    Reserve for possible loan losses

    (20,374)

    (16,563)

    Reserve for possible investment losses

    (427)

    (450)

    Total assets

    69,404,123

    74,159,096

    (Unit: million yen)

    As of

    March 31, 2025

    As of

    March 31, 2026

    LIABILITIES

    Policy reserves and others

    59,246,559

    61,255,107

    Reserves for outstanding claims

    1,426,541

    1,624,508

    Policy reserves

    57,387,967

    59,192,742

    Reserve for policyholder dividends

    432,050

    437,856

    Reinsurance payable

    301,779

    1,514,606

    Short-term bonds payable

    41,874

    7,822

    Bonds payable

    1,153,124

    1,337,337

    Other liabilities

    4,340,668

    5,109,011

    Payables under repurchase agreements

    1,699,129

    1,831,637

    Other liabilities

    2,641,538

    3,277,374

    Net defined benefit liabilities

    157,929

    19,352

    Reserve for retirement benefits of directors, executive officers and 613 556

    corporate auditors

    Reserve for possible reimbursement of prescribed claims

    1,300

    1,600

    Reserves under the special laws

    342,194

    357,500

    Reserve for price fluctuations

    342,194

    357,500

    Deferred tax liabilities

    97,710

    233,435

    Deferred tax liabilities for land revaluation

    69,806

    68,547

    Acceptances and guarantees

    11,192

    4

    Total liabilities

    65,764,753

    69,904,883

    NET ASSETS

    Capital stock

    344,353

    344,702

    Capital surplus

    330,686

    331,035

    Retained earnings

    1,376,222

    1,611,421

    Treasury stock

    (9,938)

    (16,949)

    Total shareholders' equity

    2,041,323

    2,270,210

    Net unrealized gains (losses) on securities, net of tax

    959,318

    1,372,692

    Deferred hedge gains (losses)

    (124,157)

    (205,617)

    Reserve for land revaluation

    48,984

    54,143

    Foreign currency translation adjustments

    378,906

    387,289

    Accumulated remeasurements of defined benefit plans

    126,449

    199,082

    Net unrealized gains (losses) on total policy reserves and other reserves of foreign subsidiaries, net of tax

    208,286

    176,203

    Total accumulated other comprehensive income

    1,597,788

    1,983,792

    Subscription rights to shares

    257

    210

    Total net assets

    3,639,369

    4,254,212

    Total liabilities and net assets

    69,404,123

    74,159,096

    (2) Consolidated Statement of Earnings and Comprehensive Income

    [Consolidated Statement of Earnings]

    (Unit: million yen)

    Year ended

    March 31, 2025

    Year ended

    March 31, 2026

    ORDINARY REVENUES

    9,876,615

    11,308,275

    Premium and other income

    6,799,366

    6,944,066

    Investment income

    2,528,416

    3,735,313

    Interest and dividends

    1,585,938

    1,670,711

    Gains on money held in trust

    -

    78,727

    Gains on investments in trading securities

    331,097

    680,562

    Gains on sale of securities

    570,776

    780,465

    Gains on redemption of securities

    23,236

    26,323

    Foreign exchange gains

    -

    364,124

    Reversal of reserve for possible loan losses

    4,778

    3,728

    Other investment income

    12,588

    4,875

    Gains on investments in separate accounts

    -

    125,795

    Other ordinary revenues

    548,833

    628,895

    ORDINARY EXPENSES

    9,120,887

    10,554,587

    Benefits and claims

    6,581,327

    6,447,114

    Claims

    1,998,461

    1,808,520

    Annuities

    1,063,768

    1,037,349

    Benefits

    728,415

    777,298

    Surrender values

    1,637,819

    1,289,905

    Other refunds

    1,152,863

    1,534,039

    Provision for policy reserves and others

    341,899

    1,814,937

    Provision for policy reserves

    333,462

    1,806,266

    Provision for interest on policyholder dividends

    8,437

    8,670

    Investment expenses

    842,153

    867,008

    Interest expenses

    49,312

    62,247

    Losses on money held in trust

    1,284

    -

    Losses on sale of securities

    457,799

    574,123

    Losses on valuation of securities

    22,313

    7,993

    Losses on redemption of securities

    10,502

    29,422

    Derivative transaction losses

    77,703

    95,101

    Foreign exchange losses

    126,738

    -

    Provision for reserve for possible investment losses

    292

    24

    Write-down of loans

    6,562

    3,065

    Depreciation of real estate for rent and others

    14,257

    14,826

    Other investment expenses

    71,716

    80,202

    Losses on investments in separate accounts

    3,668

    -

    Operating expenses

    988,092

    1,048,234

    Other ordinary expenses

    367,414

    377,293

    Ordinary profit

    755,728

    753,688

    (Unit: million yen)

    Year ended

    Year ended

    March 31, 2025

    March 31, 2026

    EXTRAORDINARY GAINS

    19,020

    22,507

    Gains on disposal of fixed assets

    18,881

    13,570

    Gains on change in equity

    -

    8,748

    Other extraordinary gains

    139

    188

    EXTRAORDINARY LOSSES

    75,793

    42,546

    Losses on disposal of fixed assets

    25,927

    17,110

    Impairment losses on fixed assets

    2,243

    10,058

    Provision for reserve for price fluctuations

    17,802

    15,305

    Second career special support expenses

    28,883

    -

    Other extraordinary losses

    936

    71

    Provision for reserve for policyholder dividends

    100,000

    107,500

    Income before income taxes

    598,955

    626,149

    Corporate income taxes-current

    124,754

    181,547

    Corporate income taxes-deferred

    15,793

    8,003

    Total of corporate income taxes

    140,548

    189,551

    Net income

    458,407

    436,597

    Net income attributable to shareholders of parent company

    458,407

    436,597

    [Consolidated Statement of Comprehensive Income]

    (Unit: million yen)

    Year ended

    March 31, 2025

    Year ended

    March 31, 2026

    Net income

    458,407

    436,597

    Other comprehensive income

    Net unrealized gains (losses) on securities, net of tax

    (716,189)

    427,660

    Deferred hedge gains (losses)

    (24,636)

    (76,414)

    Reserve for land revaluation

    (2,249)

    40

    Foreign currency translation adjustments

    128,323

    10,917

    Remeasurements of defined benefit plans, net of tax

    9,030

    72,539

    Net unrealized gains (losses) on total policy reserves and other reserves of foreign subsidiaries, net of tax

    61,673 (31,631)

    Share of other comprehensive income of subsidiaries and affiliates

    accounted for under the equity method

    10,005

    (22,118)

    Total other comprehensive income

    (534,042)

    380,992

    Comprehensive income

    (75,635)

    817,590

    (Details)

    Attributable to shareholders of parent company

    (75,635)

    817,590

    (3) Consolidated Statement of Changes in Net Assets

    Year ended March 31, 2025

    (Unit: million yen)

    Shareholders'equity

    Accumulated other comprehensive income

    Capital stock

    Capital surplus

    Retained earnings

    Treasury stock

    Total shareholders' equity

    Net unrealized gains (losses) on securities, net of tax

    Deferred hedge gains (losses)

    Balance at the beginning of

    the year

    344,205

    330,538

    1,214,608

    (17,258)

    1,872,093

    1,733,897

    (101,756)

    Cumulative effect of changes in accounting

    policies

    (2,100)

    (2,100)

    (63,010)

    Balance at the beginning of the year after reflecting the effect of changes in

    accounting policies

    344,205

    330,538

    1,212,507

    (17,258)

    1,869,992

    1,670,886

    (101,756)

    Changes for the year

    Issuance of new shares

    148

    148

    296

    Dividends

    (162,939)

    (162,939)

    Net income attributable to shareholders of parent

    company

    458,407

    458,407

    Purchase of treasury

    stock

    (101,849)

    (101,849)

    Disposal of treasury

    stock

    (152)

    278

    125

    Cancellation of treasury

    stock

    (108,890)

    108,890

    -

    Change in scope of

    equity method

    -

    Transfer from retained earnings to capital

    surplus

    109,043

    (109,043)

    -

    Transfer from reserve for land revaluation

    (23,010)

    (23,010)

    Others

    300

    300

    Net changes of items other than shareholders'

    equity

    (711,568)

    (22,400)

    Total changes for the year

    148

    148

    163,714

    7,319

    171,330

    (711,568)

    (22,400)

    Balance at the end of the

    year

    344,353

    330,686

    1,376,222

    (9,938)

    2,041,323

    959,318

    (124,157)

    (Unit: million yen)

    Accumulated other comprehensive income

    Subscription rights to shares

    Total net assets

    Reserve for land revaluation

    Foreign currency translation adjustments

    Accumulated remeasurements of defined benefit plans

    Net unrealized gains (losses) on total policy reserves and other reserves of foreign subsidiaries, net of tax

    Total accumulated other comprehensive income

    Balance at the beginning of

    the year

    28,223

    247,433

    117,420

    (15,457)

    2,009,761

    302

    3,882,157

    Cumulative effect of changes in accounting

    policies

    162,070

    99,060

    96,959

    Balance at the beginning of the year after reflecting the effect of changes in

    accounting policies

    28,223

    247,433

    117,420

    146,613

    2,108,821

    302

    3,979,117

    Changes for the year

    Issuance of new shares

    296

    Dividends

    (162,939)

    Net income attributable to shareholders of parent

    company

    458,407

    Purchase of treasury

    stock

    (101,849)

    Disposal of treasury

    stock

    125

    Cancellation of treasury

    stock

    -

    Change in scope of

    equity method

    -

    Transfer from retained earnings to capital

    surplus

    -

    Transfer from reserve for land

    revaluation

    (23,010)

    Others

    300

    Net changes of items other than shareholders'

    equity

    20,760

    131,472

    9,029

    61,673

    (511,032)

    (45)

    (511,077)

    Total changes for the year

    20,760

    131,472

    9,029

    61,673

    (511,032)

    (45)

    (339,747)

    Balance at the end of the

    year

    48,984

    378,906

    126,449

    208,286

    1,597,788

    257

    3,639,369

    Year ended March 31, 2026

    (Unit: million yen)

    Shareholders'equity

    Accumulated other comprehensive income

    Capital stock

    Capital surplus

    Retained earnings

    Treasury stock

    Total shareholders' equity

    Net unrealized gains (losses) on securities, net of tax

    Deferred hedge gains (losses)

    Balance at the beginning of

    the year

    344,353

    330,686

    1,376,222

    (9,938)

    2,041,323

    959,318

    (124,157)

    Cumulative effect of changes in accounting

    policies

    -

    Balance at the beginning of the year after reflecting the effect of changes in

    accounting policies

    344,353

    330,686

    1,376,222

    (9,938)

    2,041,323

    959,318

    (124,157)

    Changes for the year

    Issuance of new shares

    349

    349

    698

    Dividends

    (157,336)

    (157,336)

    Net income attributable to shareholders of parent

    company

    436,597

    436,597

    Purchase of treasury

    stock

    (107,597)

    (107,597)

    Disposal of treasury

    stock

    (77)

    1,860

    1,783

    Cancellation of treasury

    stock

    (98,725)

    98,725

    -

    Change in scope of

    equity method

    59,723

    59,723

    Transfer from retained earnings to capital

    surplus

    98,802

    (98,802)

    -

    Transfer from reserve for land

    revaluation

    (5,010)

    (5,010)

    Others

    28

    28

    Net changes of items other than shareholders'

    equity

    413,373

    (81,460)

    Total changes for the year

    349

    349

    235,199

    (7,011)

    228,886

    413,373

    (81,460)

    Balance at the end of the

    year

    344,702

    331,035

    1,611,421

    (16,949)

    2,270,210

    1,372,692

    (205,617)

    (Unit: million yen)

    Accumulated other comprehensive income

    Subscription rights to shares

    Total net assets

    Reserve for land revaluation

    Foreign currency translation adjustments

    Accumulated remeasurements of defined benefit plans

    Net unrealized gains (losses) on total policy reserves and other reserves of foreign subsidiaries, net of tax

    Total accumulated other comprehensive income

    Balance at the beginning of

    the year

    48,984

    378,906

    126,449

    208,286

    1,597,788

    257

    3,639,369

    Cumulative effect of changes in accounting

    policies

    -

    -

    Balance at the beginning of the year after reflecting the effect of changes in

    accounting policies

    48,984

    378,906

    126,449

    208,286

    1,597,788

    257

    3,639,369

    Changes for the year

    Issuance of new shares

    698

    Dividends

    (157,336)

    Net income attributable to shareholders of parent

    company

    436,597

    Purchase of treasury

    stock

    (107,597)

    Disposal of treasury

    stock

    1,783

    Cancellation of treasury

    stock

    -

    Change in scope of

    equity method

    59,723

    Transfer from retained earnings to capital

    surplus

    -

    Transfer from reserve for land

    revaluation

    (5,010)

    Others

    28

    Net changes of items other than shareholders'

    equity

    5,158

    8,382

    72,632

    (32,082)

    386,003

    (47)

    385,956

    Total changes for the year

    5,158

    8,382

    72,632

    (32,082)

    386,003

    (47)

    614,843

    Balance at the end of the

    year

    54,143

    387,289

    199,082

    176,203

    1,983,792

    210

    4,254,212

    (4) Consolidated Statement of Cash Flows

    (Unit: million yen)

    Year ended

    Year ended

    March 31, 2025

    March 31, 2026

    CASH FLOWS FROM OPERATING ACTIVITIES

    Income before income taxes

    598,955

    626,149

    Depreciation of real estate for rent and others

    14,257

    14,826

    Depreciation

    101,534

    98,095

    Impairment losses on fixed assets

    2,243

    10,058

    Amortization of goodwill

    25,230

    32,665

    Increase (decrease) in reserves for outstanding claims

    (9,310)

    33,049

    Increase (decrease) in policy reserves

    372,955

    1,958,999

    Provision for interest on policyholder dividends

    8,437

    8,670

    Provision for (reversal of) reserve for policyholder dividends

    100,000

    107,500

    Increase (decrease) in reserve for possible loan losses

    (4,715)

    (3,632)

    Increase (decrease) in reserve for possible investment losses

    (21)

    23

    Write-down of loans

    6,562

    3,065

    Increase (decrease) in net defined benefit liabilities

    (41,678)

    (37,179)

    Increase (decrease) in reserve for retirement benefits of directors, executive officers and corporate

    (60)

    (56)

    auditors

    Increase (decrease) in reserve for possible reimbursement of prescribed claims

    300

    300

    Increase (decrease) in reserve for price fluctuations

    17,802

    15,305

    Interest and dividends

    (1,585,938)

    (1,670,711)

    Securities related losses (gains)

    (430,826)

    (1,001,607)

    Interest expenses

    49,312

    62,247

    Foreign exchange losses (gains)

    126,738

    (364,124)

    Losses (gains) on disposal of fixed assets

    1,100

    1,652

    Equity in losses (income) of affiliates

    (3,526)

    (23,055)

    Losses (gains) on sale of stocks of subsidiaries and affiliated companies

    -

    (145)

    Decrease (increase) in reinsurance receivable

    5,253

    (32,360)

    Decrease (increase) in other assets unrelated to investing and financing activities

    (111,816)

    (1,687,768)

    Increase (decrease) in reinsurance payable

    (192,710)

    1,202,401

    Increase (decrease) in other liabilities unrelated to investing and financing activities

    (186,955)

    119,068

    Others, net

    218,212

    (123,738)

    Subtotal

    (918,663)

    (650,298)

    Interest and dividends received

    1,812,356

    2,016,842

    Interest paid

    (49,724)

    (58,230)

    Policyholder dividends paid

    (99,028)

    (110,364)

    Others, net

    (50,563)

    (274,135)

    Corporate income taxes (paid) refund

    (101,796)

    (131,654)

    Net cash flows provided by (used in) operating activities

    592,578

    792,158

    (Unit: million yen)

    Year ended March 31, 2025

    Year ended March 31, 2026

    CASH FLOWS FROM INVESTING ACTIVITIES

    Net decrease (increase) in cash and deposits

    (19,328)

    (116,348)

    Purchases of monetary claims bought

    (20,465)

    (24,731)

    Proceeds from sale and redemption of monetary claims bought

    33,458

    35,647

    Purchases of money held in trust

    (263,790)

    (464,952)

    Proceeds from decrease in money held in trust

    251,365

    58,516

    Purchases of securities

    (13,549,721)

    (18,529,564)

    Proceeds from sale and redemption of securities

    12,807,996

    17,814,152

    Origination of loans

    (1,265,718)

    (1,018,068)

    Proceeds from collection of loans

    1,050,850

    1,162,295

    Net increase (decrease) in short-term investing

    286,211

    217,780

    Others, net

    -

    132

    Total of net cash provided by (used in) investment transactions

    (689,142)

    (865,141)

    Total of net cash provided by (used in) operating activities and investment transactions

    (96,563)

    (72,983)

    Acquisition of tangible fixed assets

    (60,115)

    (77,168)

    Proceeds from sale of tangible fixed assets

    47,011

    57,424

    Acquisition of intangible fixed assets

    (44,347)

    (42,618)

    Proceeds from sale of intangible fixed assets

    -

    24

    Acquisitions of stock of subsidiaries resulting in change in scope of consolidation

    (233,785)

    -

    Proceeds from acquisitions of stock of subsidiaries resulting in change in scope of consolidation

    -

    1,245

    Payments for execution of assets retirement obligations

    (81)

    -

    Acquisitions of stock of subsidiaries

    -

    (21)

    Net cash flows provided by (used in) investing activities

    (980,460)

    (926,255)

    CASH FLOWS FROM FINANCING ACTIVITIES

    Proceeds from borrowings

    -

    218,500

    Repayment of borrowings

    (1,720)

    (213,385)

    Proceeds from issuing bonds

    316,230

    185,921

    Redemption of bonds

    (111,718)

    -

    Repayment of financial lease obligations

    (11,141)

    (2,548)

    Net increase (decrease) in short-term financing

    (813)

    (51,140)

    Purchase of treasury stock

    (101,849)

    (107,597)

    Cash dividends paid

    (162,356)

    (156,780)

    Acquisitions of stock of subsidiaries that do not result in change in scope of consolidation

    (200)

    (199)

    Others, net

    0

    0

    Net cash flows provided by (used in) financing activities

    (73,570)

    (127,230)

    Effect of exchange rate changes on cash and cash equivalents

    2,610

    35,387

    Net increase (decrease) in cash and cash equivalents

    (458,841)

    (225,940)

    Cash and cash equivalents at the beginning of the year

    2,772,370

    2,313,529

    Cash and cash equivalents at the end of the year

    2,313,529

    2,087,588

    (5) Notes to the Consolidated Financial Statements (Notes on Going-Concern Assumptions)

    None

    (Changes in Accounting Policies)

    Effective the fiscal year ended March 31, 2026, certain consolidated overseas subsidiaries have applied the accounting standard (ASC) "Financial Services - Insurance" (Topic 944) (ASU No. 2018-12 issued on August 15, 2018, ASU No. 2019-09 issued on November 15, 2019, ASU No. 2020-11 issued on November 5, 2020 and ASU No. 2022-05 issued on December 15, 2022) issued by the Financial Accounting Standards Board (FASB).

    Through this application, the accounting treatment of the liability for future policy benefits, the measurement of benefits with market risks at fair value, and the amortization methods of deferred acquisition costs of insurance contracts have been updated.

    This change in accounting policy has been applied retrospectively, and the consolidated financial statements for the previous fiscal year have been retroactively restated.

    As a result, income before income taxes for the previous fiscal year increased by ¥36,655 million compared to that before the retrospective application. In addition, policy reserves and others for the previous fiscal year decreased by ¥319,646 million and other assets for the previous fiscal year decreased by ¥80,428 million. Furthermore, as a result of the cumulative impact reflected in net assets at the beginning balance of the previous fiscal year, the beginning balance of retained earnings decreased by ¥2,100 million, and the beginning balance of accumulated other comprehensive income increased by ¥99,060 million.

    (Segment Information and Others) [Segment Information]

    1. Overview of reportable segments

      The reportable segments of the Company are components of the Company about which separate financial information is available. The segments are subject to periodic review to enable the Company's Board of Directors to decide on allocation of business resources and evaluate business performance.

      The Company is a holding company which manages life insurance companies in Japan and elsewhere as well as other subsidiaries and affiliated companies. These companies are subject to regulations of the Insurance Business Act.

      The Company's operations are therefore segmented based on the operations of its subsidiaries and affiliated companies and the Company's three reportable segments are the Domestic Insurance Business, the Overseas Insurance Business, and Other Business.

      The Domestic Insurance Business consists of subsidiaries that engage in the insurance business in Japan. The Overseas Insurance Business consists of subsidiaries and affiliated companies that engage in the insurance business overseas. The Company, subsidiaries and affiliated companies that do not operate either the Domestic Insurance Business or the Overseas Insurance Business are segmented as Other Business and mainly consist of business administration of the group companies and non-insurance businesses (asset management business and new fields of business).

    2. Method of calculating ordinary revenues, income or loss, assets and liabilities and others by reportable segment Figures for reportable segment income are based on ordinary profit.

      Intersegment revenue is based on market prices.

    3. Information on ordinary revenues, income or loss, assets and liabilities, and others by reportable segment For the fiscal year ended March 31, 2026

    (Unit: million yen)

    Reportable segment

    Adjustments (Note 2)

    Amount on consolidated financial statements (Note 3)

    Domestic Insurance Business

    Overseas Insurance Business

    Other Business

    Total

    Ordinary revenues (Note 1)

    8,155,625

    3,523,786

    79,050

    11,758,462

    (450,187)

    11,308,275

    Intersegment transfers

    514,005

    35,578

    392,427

    942,011

    (942,011)

    -

    Total

    8,669,631

    3,559,364

    471,478

    12,700,474

    (1,392,198)

    11,308,275

    Segment income (loss)

    676,269

    112,629

    340,204

    1,129,103

    (375,415)

    753,688

    Segment assets

    45,559,593

    28,033,406

    4,478,272

    78,071,272

    (3,912,175)

    74,159,096

    Segment liabilities

    42,438,108

    26,847,438

    1,601,056

    70,886,603

    (981,720)

    69,904,883

    Other relevant information

    Depreciation of real estate for rent and others

    14,817

    9

    -

    14,826

    -

    14,826

    Depreciation

    55,002

    37,797

    5,295

    98,095

    -

    98,095

    Amortization of goodwill

    1,037

    11,568

    20,059

    32,665

    -

    32,665

    Interest and dividends

    1,026,992

    646,435

    387,122

    2,060,549

    (389,838)

    1,670,711

    Interest expenses

    26,488

    28,567

    20,192

    75,248

    (13,000)

    62,247

    Equity in income (loss) of affiliates

    -

    11,144

    11,911

    23,055

    -

    23,055

    Extraordinary gains

    13,701

    48

    8,893

    22,643

    (136)

    22,507

    Extraordinary losses

    33,126

    9,452

    69

    42,649

    (102)

    42,546

    [Impairment losses]

    [1,764]

    [8,243]

    [50]

    [10,058]

    [-]

    [10,058]

    Taxes

    156,208

    28,868

    4,484

    189,561

    (9)

    189,551

    Investments in affiliated companies

    -

    154,315

    226,967

    381,282

    -

    381,282

    Increase in tangible fixed assets and intangible fixed assets

    162,365

    4,098

    1,534

    167,998

    -

    167,998

    Note: 1. Ordinary revenues, instead of sales, are presented here.

  2. Adjusted amounts were as follows.

    1. Adjustment for ordinary revenues of ¥(450,187) million was mainly related to ordinary revenues including other ordinary revenues of ¥432,924 million and ordinary expenses including other ordinary expenses of ¥12,968 million reconciled to provision for policy reserves and other ordinary revenues in the Consolidated Statement of Earnings.

    2. Adjustment for segment income (loss) of ¥(375,415) million was mainly related to elimination of dividend income from subsidiaries and affiliated companies.

    3. Adjustment for segment assets of ¥(3,912,175) million was mainly related to elimination of stocks of subsidiaries and affiliated companies.

    4. Adjustment for segment liabilities of ¥(981,720) million was mainly related to elimination of intersegment receivables and payables.

    5. Adjustment for others was mainly related to elimination of intersegment transactions.

  3. Segment income (loss) is reconciled with ordinary profit booked in the Consolidated Statement of Earnings.

[Other Related Information]

For the fiscal year ended March 31, 2026

  1. Product (Service) Segment Information

    (Unit: million yen)

    Domestic Insurance Business

    Overseas Insurance Business

    Other Business

    Total

    Premium and other income

    5,108,737

    1,835,328

    -

    6,944,066

  2. Geographic Segment Information

    1. Ordinary Revenues

      (Unit: million yen)

      Japan

      United States of America

      Other Areas

      Total

      7,501,192

      2,111,276

      1,695,807

      11,308,275

      Note: 1. Ordinary revenues, instead of sales, are presented here.

      2. Based on the location of customers, ordinary revenues are classified by country or region.

    2. Tangible fixed assets

      The geographic segment information has been omitted as more than 90% of the Group's tangible fixed assets derive from its business unit in Japan.

  3. Major Customer Information

The major customer information has been omitted as no single customer accounts for 10% or more of the Group's ordinary revenues.

[Impairment Losses on Fixed Assets by Reportable Segment] For the fiscal year ended March 31, 2026

The information on impairment losses on fixed assets by reportable segment has been omitted as it is explained in [Segment Information].

[Amortization of Goodwill and Unamortized Amount of Goodwill by Reportable Segment]

For the fiscal year ended March 31, 2026

(Unit: million yen)

Domestic Insurance Business

Overseas Insurance Business

Other Business

Total

Amortization of goodwill

1,037

11,568

20,059

32,665

Unamortized amount of goodwill

12,193

124,593

165,488

302,276

[Gain on Negative Goodwill by Reportable Segment] For the fiscal year ended March 31, 2026

Not applicable

(Per-share Information)

Net assets per share as of March 31, 2026: ¥ 1,181.36

Net income per share for the year ended March 31, 2026: ¥ 119.83

Diluted net income per share for the year ended March 31, 2026: ¥ 119.82 Note.

  1. The Company conducted a 1:4 share split on April 1, 2025. Net assets per share, net income per share and diluted net income per share are calculated assuming that the share split was conducted at the beginning of the current fiscal year.

  2. Reconciliation of net income per share and diluted net income per share was as follows:

    Year ended March 31, 2026 (Unit: million yen)

    Net income per share

    Net income attributable to shareholders of parent company …………………… ¥ 436,597 Net income attributable to other than shareholders of common stock ………… -Net income attributable to shareholders of parent company of common stock … ¥ 436,597 Average number of common stock outstanding: 3,643,385 thousand shares

    Diluted net income per share

    Adjustments to net income attributable to shareholders of parent company

    -

    Increase in the number of common stock: 456 thousand shares

    (Increase in the number of common stock attributable to subscription

    rights

    to

    shares: 456

    thousand shares)

    Outline of the dilutive shares which are not counted in the basis of calculation of diluted net income per share because they do not have dilutive effect: Not applicable

  3. Reconciliation of net assets per share was as follows:

    As of March 31, 2026 (Unit: million yen) Net assets ……………………………………… ¥ 4,254,212 Adjustments …………………………………… ¥ 210 Subscription rights to shares ……………… ¥ 210

    Net assets attributable to common stock ……… ¥ 4,254,002 Number of common stock outstanding: 3,600,951 thousand shares

  4. For the calculation of net income per share, the shares held by "the Stock Granting Trust (J-ESOP)" were included in treasury stock excluded from the average number of common stock outstanding. The average number of the shares held by the J-ESOP during the year ended March 31, 2026 was 14,135 thousand shares. For the calculation of net assets per share, the shares held by the J-ESOP were included in treasury stock excluded from the number of common stock outstanding. The number of the shares held by the J-ESOP as of March 31, 2026 was 18,079 thousand shares.

(Subsequent Events)

  1. Protective Life Corporation, a consolidated subsidiary of the Company, made Portfolio Holding, Inc. a subsidiary of the Company on January 1, 2026 (U.S. time) as it satisfied all customary closing conditions precedent to becoming a subsidiary.

    1. Overview of the business combination

      1. Name and business of the acquired company Company name: Portfolio Holding, Inc.

        Business: Non-life insurance business

      2. Purpose of the business combination

        Portfolio Holding, Inc. was founded in 1990 and is a leading provider of reinsurance management services and finance and insurance products throughout the U.S. Portfolio Holding, Inc. features a fee-based business model centered around dealer-participating reinsurance programs, offering a stable revenue base and a sales network that is highly complementary to Protective Life Corporation's Asset Protection Division product offerings. Through this acquisition, the Company expects to accelerate the growth of Protective Life Corporation's Asset Protection Division by increasing the proportion of fee-based income, while also expanding Protective Life Corporation's business scale, enhancing profitability, and strengthening its customer base.

      3. Date of business combination January 1, 2026

      4. Ratio of voting rights acquired 100%

      5. Main reason for determining the controlling company

        Protective Life Corporation was determined to be the controlling company as it owns 100% of voting rights in Portfolio Holding, Inc..

    2. Acquisition costs

      Consideration for the acquisition Cash Approx. USD1.0 billion Acquisition costs Approx. USD1.0 billion

      * Consideration for the acquisition may change based on an agreement.

    3. Impact on the consolidated financial results

    The acquisition has no impact on the consolidated results of the current fiscal year. The impact on the consolidated results for subsequent fiscal years is currently under review.

  2. Protective Life Corporation, a consolidated subsidiary of the Company, has decided and entered into an agreement to acquire Obsidian Insurance Holdings, Inc. that operates the non-life insurance business in the U.S. on April 28, 2026 (U.S. time).

  1. Purpose of the acquisition

    Founded in 2020, Obsidian Insurance Holdings, Inc. operates as a hybrid fronting carrier, supporting property and casualty insurance programs that serve specialized risks, many of which are generally not served by the commercial insurance market. Through the provision of specialized insurance programs and disciplined underwriting management, Obsidian Insurance Holdings, Inc. has established a focused and well-managed platform since its founding. This acquisition will add a complementary line of business to Protective Life Corporation's product suite, and it is expected to contribute to business diversification and earnings stabilization.

  2. Overview of the acquired company

    1. Company name: Obsidian Insurance Holdings, Inc.

    2. Business: Non-life insurance business

    3. Fee revenue, etc. (FY2025 results): USD1.0 billion

  3. Acquisition price

    The acquisition price is undisclosed due to an agreement between the parties.

    The acquisition price is determined based on a comprehensive consideration of valuations by a third-party

    valuation agent and other factors.

  4. Completion of acquisition

This acquisition is subject to regulatory approvals and other conditions and is expected to be completed in the fourth quarter of fiscal year 2026 or the first quarter of fiscal year March 2027.

It has no impact on the consolidated financial results of the current fiscal year. The impact on the consolidated results for subsequent fiscal years is currently under review.